VIM and cancer: Similarly, EGCG suppressed the expression of vimentin in non-small cell lung cancer H1299 cells (114), decreased TGF-β1-induced EMT in anaplastic thyroid carcinoma 8505C cells (115), downregulated the expression of EMT phenotypes of cancer stem cells (CSCs) (116), and inhibited these cancer cells invasion and migration.